Grants per year
Personal profile
Research Interests
Myeloma, Transplantation
Certifications and Licenses
| Internal Medicine |
Training Experience
| 1991 | Residency, Bombay University, India |
| 1992 | Fellowship, Hadassah University Hospital, Israel |
Education/Academic qualification
MD, University of Mumbai
… → 1991
Research interests
- Amyloidosis
- Monoclonal Antibodies
- Multiple Myeloma
- Plasma Cell Disorders
- Stem Cell Transplant
- Waldenstroms
Fingerprint
Dive into the research topics where Seema Singhal is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Prot #ALLO-605-201: A Single-Arm, Open-Label, Phase 1/2 Study Evaluating the Safety, Efficacy, and Cellular Kinetics/Pharmacodynamics of ALLO-647 and ALLO-605, an Anti-BCMA Allogeneic CAR T Cell Therapy in Patients with Relapsed/Refractory Multiple Myelom
Covance Inc., Allogene Therapeutics, Inc.
2/1/22 → 2/1/25
Project: Research project
-
Prot #BB2121-MM-007: An Exploratory Phase 1/2 Trial to Determine Recommended Phase 2 Dose (RP2D), Safety and Preliminary Efficacy of bb2121 (Ide-cel) Combinations in Subjects with Relapsed/Refractory Multiple Myeloma (KarMMa-7)
DrugDev Inc., Celgene Corporation
8/6/21 → 8/6/24
Project: Research project
-
Prot #209627: A Phase I Study to Evaluate the Pharmacokinetics and Safety of Belantamab Mafodotin Monotherapy in Participants with Relapsed or Refractory Multiple Myeloma Who Have Normal and Varying Degrees of Impaired Hepatic Function (DREAMM 13)
Quintiles, Inc., GlaxoSmithKline LLC
3/12/21 → 3/12/24
Project: Research project
-
A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry
Du, Z., Weinhold, N., Song, G. C., Rand, K. A., Van Den Berg, D. J., Hwang, A. E., Sheng, X., Hom, V., Ailawadhi, S., Nooka, A. K., Singhal, S., Pawlish, K., Peters, E. S., Bock, C., Mohrbacher, A., Stram, A., Berndt, S. I., Blot, W. J., Casey, G., Stevens, V. L., & 50 others, Jan 14 2020, In: Blood Advances. 4, 1, p. 181-190 10 p.Research output: Contribution to journal › Article › peer-review
Open Access8 Scopus citations -
Variability in cytogenetic testing for multiple myeloma: a comprehensive analysis from across the United States
Yu, Y., Wade, N. B., Hwang, A. E., Nooka, A. K., Fiala, M. A., Mohrbacher, A., Peters, E. S., Pawlish, K., Bock, C., van Den, D. J., Rand, K. A., Stram, D., Conti, D. V., Auclair, D., Colditz, G. A., Mehta, J., Haiman, C. A., Terebelo, H., Janakiraman, N., Singhal, S., & 9 others, Oct 1 2020, In: JCO Oncology Practice. 16, 10, p. E1169-E1180Research output: Contribution to journal › Article › peer-review
5 Scopus citations -
Multiple myeloma, version 1.2020 featured updates to the NCCN guidelines
Kumar, S. K., Callander, N. S., Hillengass, J., Liedtke, M., Baljevic, M., Campagnaro, E., Castillo, J. J., Chandler, J. C., Cornell, R. F., Costello, C., Efebera, Y., Faiman, M., Garfall, A., Godby, K., Holmberg, L., Htut, M., Huff, C. A., Kang, Y., Landgren, O., Malek, E., & 11 others, 2019, In: JNCCN Journal of the National Comprehensive Cancer Network. 17, 10, p. 1154-1165 12 p.Research output: Contribution to journal › Review article › peer-review
Open Access75 Scopus citations -
Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial
KEYNOTE-183 Investigators, Sep 2019, In: The Lancet Haematology. 6, 9, p. e459-e469Research output: Contribution to journal › Article › peer-review
110 Scopus citations -
Phase I study of the anti-FcRH5 antibody-drug conjugate DFRF4539A in relapsed or refractory multiple myeloma
Stewart, A. K., Krishnan, A. Y., Singhal, S., Boccia, R. V., Patel, M. R., Niesvizky, R., Chanan-Khan, A. A., Ailawadhi, S., Brumm, J., Mundt, K. E., Hong, K., McBride, J., Shon-Nguyen, Q., Xiao, Y., Ramakrishnan, V., Polson, A. G., Samineni, D., Leipold, D., Humke, E. W., McClellan, J. S., & 1 others, Feb 1 2019, In: Blood cancer journal. 9, 2, 17.Research output: Contribution to journal › Article › peer-review
Open Access22 Scopus citations